IRE1α RNase-dependent lipid homeostasis promotes survival in Myc-transformed cancers
Myc activation is a primary oncogenic event in many human cancers; however, these transcription factors are difficult to inhibit pharmacologically, suggesting that Myc-dependent downstream effectors may be more tractable therapeutic targets. Here, we show that Myc overexpression induces endoplasmic reticulum (ER) stress and engages the inositol-requiring enzyme 1α (IRE1α)/X-box binding protein 1 (XBP1) pathway through multiple molecular mechanisms in a variety of c-Myc- and N-Myc-dependent cancers. In particular, Myc-overexpressing cells require IRE1α/XBP1 signaling for sustained growth and survival in vitro and in vivo, dependent on elevated stearoyl-CoA-desaturase 1 (SCD1) activity. Pharmacological and genetic XBP1 inhibition induces Myc-dependent apoptosis, which is alleviated by exogenous unsaturated fatty acids. Of note, SCD1 inhibition phenocopies IRE1α RNase activity suppression in vivo. Furthermore, IRE1α inhibition enhances the cytotoxic effects of standard chemotherapy drugs used to treat c-Myc-overexpressing Burkitt's lymphoma, suggesting that inhibiting the IRE1α/XBP1 pathway is a useful general strategy for treatment of Myc-driven cancers.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2018 |
|---|---|
| Erschienen: |
2018 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:128 |
|---|---|
| Enthalten in: |
The Journal of clinical investigation - 128(2018), 4 vom: 02. Apr., Seite 1300-1316 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Xie, Hong [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 10.09.2019 Date Revised 04.12.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1172/JCI95864 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM280416598 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM280416598 | ||
| 003 | DE-627 | ||
| 005 | 20231225025300.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1172/JCI95864 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0934.xml |
| 035 | |a (DE-627)NLM280416598 | ||
| 035 | |a (NLM)29381485 | ||
| 035 | |a (PII)95864 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Xie, Hong |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a IRE1α RNase-dependent lipid homeostasis promotes survival in Myc-transformed cancers |
| 264 | 1 | |c 2018 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 10.09.2019 | ||
| 500 | |a Date Revised 04.12.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Myc activation is a primary oncogenic event in many human cancers; however, these transcription factors are difficult to inhibit pharmacologically, suggesting that Myc-dependent downstream effectors may be more tractable therapeutic targets. Here, we show that Myc overexpression induces endoplasmic reticulum (ER) stress and engages the inositol-requiring enzyme 1α (IRE1α)/X-box binding protein 1 (XBP1) pathway through multiple molecular mechanisms in a variety of c-Myc- and N-Myc-dependent cancers. In particular, Myc-overexpressing cells require IRE1α/XBP1 signaling for sustained growth and survival in vitro and in vivo, dependent on elevated stearoyl-CoA-desaturase 1 (SCD1) activity. Pharmacological and genetic XBP1 inhibition induces Myc-dependent apoptosis, which is alleviated by exogenous unsaturated fatty acids. Of note, SCD1 inhibition phenocopies IRE1α RNase activity suppression in vivo. Furthermore, IRE1α inhibition enhances the cytotoxic effects of standard chemotherapy drugs used to treat c-Myc-overexpressing Burkitt's lymphoma, suggesting that inhibiting the IRE1α/XBP1 pathway is a useful general strategy for treatment of Myc-driven cancers | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Cancer | |
| 650 | 4 | |a Cell stress | |
| 650 | 4 | |a Drug therapy | |
| 650 | 4 | |a Oncology | |
| 650 | 4 | |a Therapeutics | |
| 650 | 7 | |a MYC protein, human |2 NLM | |
| 650 | 7 | |a Proto-Oncogene Proteins c-myc |2 NLM | |
| 650 | 7 | |a ERN1 protein, human |2 NLM | |
| 650 | 7 | |a EC 2.7.11.1 |2 NLM | |
| 650 | 7 | |a Protein Serine-Threonine Kinases |2 NLM | |
| 650 | 7 | |a EC 2.7.11.1 |2 NLM | |
| 650 | 7 | |a Endoribonucleases |2 NLM | |
| 650 | 7 | |a EC 3.1.- |2 NLM | |
| 700 | 1 | |a Tang, Chih-Hang Anthony |e verfasserin |4 aut | |
| 700 | 1 | |a Song, Jun H |e verfasserin |4 aut | |
| 700 | 1 | |a Mancuso, Anthony |e verfasserin |4 aut | |
| 700 | 1 | |a Del Valle, Juan R |e verfasserin |4 aut | |
| 700 | 1 | |a Cao, Jin |e verfasserin |4 aut | |
| 700 | 1 | |a Xiang, Yan |e verfasserin |4 aut | |
| 700 | 1 | |a Dang, Chi V |e verfasserin |4 aut | |
| 700 | 1 | |a Lan, Roy |e verfasserin |4 aut | |
| 700 | 1 | |a Sanchez, Danielle J |e verfasserin |4 aut | |
| 700 | 1 | |a Keith, Brian |e verfasserin |4 aut | |
| 700 | 1 | |a Hu, Chih-Chi Andrew |e verfasserin |4 aut | |
| 700 | 1 | |a Simon, M Celeste |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Journal of clinical investigation |d 1924 |g 128(2018), 4 vom: 02. Apr., Seite 1300-1316 |w (DE-627)NLM000005487 |x 1558-8238 |7 nnns |
| 773 | 1 | 8 | |g volume:128 |g year:2018 |g number:4 |g day:02 |g month:04 |g pages:1300-1316 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1172/JCI95864 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 128 |j 2018 |e 4 |b 02 |c 04 |h 1300-1316 | ||